Integrated GlycoProteome Analyzer (I-GPA) for Automated Identification and Quantitation of Site-Specific N-Glycosylation

Human glycoproteins exhibit enormous heterogeneity at each N-glycosite, but few studies have attempted to globally characterize the site-specific structural features. We have developed Integrated GlycoProteome Analyzer (I-GPA) including mapping system for complex N-glycoproteomes, which combines methods for tandem mass spectrometry with a database search and algorithmic suite. Using an N-glycopeptide database that we constructed, we created novel scoring algorithms with decoy glycopeptides, where 95 N-glycopeptides from standard α1-acid glycoprotein were identified with 0% false positives, giving the same results as manual validation. Additionally automated label-free quantitation method was first developed that utilizes the combined intensity of top three isotope peaks at three highest MS spectral points. The efficiency of I-GPA was demonstrated by automatically identifying 619 site-specific N-glycopeptides with FDR ≤ 1%, and simultaneously quantifying 598 N-glycopeptides, from human plasma samples that are known to contain highly glycosylated proteins. Thus, I-GPA platform could make a major breakthrough in high-throughput mapping of complex N-glycoproteomes, which can be applied to biomarker discovery and ongoing global human proteome project.

[1]  Xianghuo He,et al.  SERPINA5 inhibits tumor cell migration by modulating the fibronectin‐integrin β1 signaling pathway in hepatocellular carcinoma , 2014, Molecular oncology.

[2]  Aneeka M Hancock,et al.  Glycoproteomics in neurodegenerative diseases. , 2010, Mass spectrometry reviews.

[3]  R. Dwek,et al.  Glycosylation of serum ribonuclease 1 indicates a major endothelial origin and reveals an increase in core fucosylation in pancreatic cancer. , 2007, Glycobiology.

[4]  Chen-Chun Chen,et al.  MAGIC: an automated N-linked glycoprotein identification tool using a Y1-ion pattern matching algorithm and in silico MS² approach. , 2015, Analytical chemistry.

[5]  Serenus Hua,et al.  Automated assignments of N- and O-site specific glycosylation with extensive glycan heterogeneity of glycoprotein mixtures. , 2013, Analytical chemistry.

[6]  S. Fukushima,et al.  alpha(2)-Macroglobulin: a novel cytochemical marker characterizing preneoplastic and neoplastic rat liver lesions negative for hitherto established cytochemical markers. , 2004, The American journal of pathology.

[7]  S. Hanash,et al.  The Chromosome-Centric Human Proteome Project for cataloging proteins encoded in the genome , 2012, Nature Biotechnology.

[8]  L. Drahos,et al.  High-performance liquid chromatography coupled to mass spectrometry methodology for analyzing site-specific N-glycosylation patterns. , 2012, Journal of chromatography. A.

[9]  H. Kuwano,et al.  Development of a Novel System for Mass Spectrometric Analysis of Cancer-Associated Fucosylation in Plasma α 1-Acid Glycoprotein , 2013, BioMed research international.

[10]  Yong J. Kil,et al.  Byonic: Advanced Peptide and Protein Identification Software , 2012, Current protocols in bioinformatics.

[11]  Obi L Griffith,et al.  Loss of cell-surface laminin anchoring promotes tumor growth and is associated with poor clinical outcomes. , 2012, Cancer research.

[12]  S. Nishimura,et al.  Development of quantitative plasma N-glycoproteomics using label-free 2-D LC-MALDI MS and its applicability for biomarker discovery in hepatocellular carcinoma. , 2011, Journal of proteomics.

[13]  Scott R. Kronewitter,et al.  The development of retrosynthetic glycan libraries to profile and classify the human serum N‐linked glycome , 2009, Proteomics.

[14]  N. Edwards,et al.  Site-specific Glycoforms of Haptoglobin in Liver Cirrhosis and Hepatocellular Carcinoma* , 2013, Molecular & Cellular Proteomics.

[15]  Salvatore Panico,et al.  Prediagnostic plasma testosterone, sex hormone‐binding globulin, IGF‐I and hepatocellular carcinoma: Etiological factors or risk markers? , 2014, International journal of cancer.

[16]  Heba F Pasha,et al.  Clinical significance of serum clusterin as a biomarker for evaluating diagnosis and metastasis potential of viral-related hepatocellular carcinoma. , 2012, Clinical biochemistry.

[17]  R. Aebersold,et al.  A High-Confidence Human Plasma Proteome Reference Set with Estimated Concentrations in PeptideAtlas* , 2011, Molecular & Cellular Proteomics.

[18]  Radoslav Goldman,et al.  Exploring site-specific N-glycosylation microheterogeneity of haptoglobin using glycopeptide CID tandem mass spectra and glycan database search. , 2013, Journal of proteome research.

[19]  Nicole Rusk Causal mutations in a haploid landscape , 2011, Nature Methods.

[20]  S. Hanash,et al.  Towards an integrated proteomic and glycomic approach to finding cancer biomarkers , 2009, Genome Medicine.

[21]  Hoguen Kim,et al.  A lectin-coupled, targeted proteomic mass spectrometry (MRM MS) platform for identification of multiple liver cancer biomarkers in human plasma. , 2012, Journal of proteomics.

[22]  Haixu Tang,et al.  Label-free glycopeptide quantification for biomarker discovery in human sera. , 2014, Journal of proteome research.

[23]  Suh-Yuen Liang,et al.  Sweet-Heart - an integrated suite of enabling computational tools for automated MS2/MS3 sequencing and identification of glycopeptides. , 2013, Journal of proteomics.

[24]  M. Tajiri,et al.  Hydrophilic affinity isolation and MALDI multiple-stage tandem mass spectrometry of glycopeptides for glycoproteomics. , 2004, Analytical chemistry.

[25]  Benny Zee,et al.  Application of Classification Tree and Neural Network Algorithms to the Identification of Serological Liver Marker Profiles for the Diagnosis of Hepatocellular Carcinoma , 2001, Oncology.

[26]  Yusuke Nakamura,et al.  Quantitative structural characterization of local N-glycan microheterogeneity in therapeutic antibodies by energy-resolved oxonium ion monitoring. , 2012, Analytical chemistry.

[27]  Tsung-Hsien Pu,et al.  Novel LC-MS² product dependent parallel data acquisition function and data analysis workflow for sequencing and identification of intact glycopeptides. , 2014, Analytical chemistry.

[28]  H. Shiraha,et al.  Clinical utility of serum fucosylated hemopexin in Japanese patients with hepatocellular carcinoma , 2012, Hepatology research : the official journal of the Japan Society of Hepatology.

[29]  J. Kim,et al.  QUANTITATIVE MASS SPECTROMETRIC ANALYSIS OF GLYCOPROTEINS COMBINED WITH ENRICHMENT METHODS , 2014, Mass spectrometry reviews.

[30]  C. Van Steenkiste,et al.  Alteration of protein glycosylation in liver diseases. , 2009, Journal of hepatology.

[31]  M. Raftery,et al.  Detection and Characterization of Low Abundance Glycopeptides Via Higher-Energy C-Trap Dissociation and Orbitrap Mass Analysis , 2011, Journal of The American Society for Mass Spectrometry.

[32]  I. Rudan,et al.  Comparative Performance of Four Methods for High-throughput Glycosylation Analysis of Immunoglobulin G in Genetic and Epidemiological Research , 2014, Molecular & Cellular Proteomics.

[33]  E. Go,et al.  Label-free quantitation: A new glycoproteomics approach , 2009, Journal of the American Society for Mass Spectrometry.

[34]  Shisheng Sun,et al.  Selective isolation and analysis of glycoprotein fractions and their glycomes from hepatocellular carcinoma sera , 2013, Proteomics.

[35]  Kit S. Lam,et al.  A Serum Glycomics Approach to Breast Cancer Biomarkers*S , 2007, Molecular & Cellular Proteomics.

[36]  A. Tessitore,et al.  Serum Biomarkers Identification by Mass Spectrometry in High-Mortality Tumors , 2013, International journal of proteomics.

[37]  Haixu Tang,et al.  Computational framework for identification of intact glycopeptides in complex samples. , 2014, Analytical chemistry.

[38]  Jonathan C Trinidad,et al.  N- and O-Glycosylation in the Murine Synaptosome* , 2013, Molecular & Cellular Proteomics.

[39]  Chen Li,et al.  Identification and confirmation of biomarkers using an integrated platform for quantitative analysis of glycoproteins and their glycosylations. , 2010, Journal of proteome research.

[40]  Hongyang Wang,et al.  Development of Glycoprotein Capture-Based Label-Free Method for the High-throughput Screening of Differential Glycoproteins in Hepatocellular Carcinoma* , 2011, Molecular & Cellular Proteomics.

[41]  Nichollas E. Scott,et al.  Site-specific glycan-peptide analysis for determination of N-glycoproteome heterogeneity. , 2013, Journal of proteome research.

[42]  Florian Gnad,et al.  Precision Mapping of an In Vivo N-Glycoproteome Reveals Rigid Topological and Sequence Constraints , 2010, Cell.

[43]  Bin Gao,et al.  The complement system in liver diseases. , 2006, Cellular & molecular immunology.